Nipro Corporation (Osaka, Japan) has signed a definitive agreement to acquire Infraredx, Inc. (Burlington, Massachusetts).
Nipro Corporation (Osaka, Japan) has signed a definitive agreement to acquire Infraredx, Inc. (Burlington, Massachusetts). Nipro Corporation has broad holdings in pharmaceuticals and medical devices. Infraredx is an intravascular imaging company working to advance the diagnosis and management of coronary artery disease globally.
The agreement combines Nipro’s global cardiovascular portfolio with Infraredx’s industry expertise in near infrared spectroscopy and intravascular ultrasound. The agreement will help introduce Nipro’s cardiovascular product line into the United States, and continue Infraredx’s mission to provide cardiologists with advanced imaging tools designed to predict heart attacks and prevent them.
“We are pleased to combine our strengths to meet the demands of the marketplace and continue to deliver to the medical community cardiovascular imaging systems that hold the potential to revolutionize the management of cardiovascular disease,” Jason Bottiglieri, president and CEO of Infraredx, said in a statement.
The acquisition, which is subject to certain conditions, is expected to close in October 2015.
